These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18161120

  • 21. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May 05; 147(18):44-5. PubMed ID: 15934589
    [No Abstract] [Full Text] [Related]

  • 22. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H.
    Clin Calcium; 2008 Oct 05; 18(10):1442-50. PubMed ID: 18830041
    [Abstract] [Full Text] [Related]

  • 23. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov 16; 148(46):48-9. PubMed ID: 17615790
    [No Abstract] [Full Text] [Related]

  • 24. [Patient compliance program aids therapy success].
    MMW Fortschr Med; 2009 Mar 12; 151(11):47. PubMed ID: 19469207
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM.
    Am Fam Physician; 2004 Oct 01; 70(7):1293-300. PubMed ID: 15508540
    [Abstract] [Full Text] [Related]

  • 26. [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].
    Praxis (Bern 1994); 2004 Sep 01; 93(36):1454. PubMed ID: 15487859
    [No Abstract] [Full Text] [Related]

  • 27. Going on a drug holiday?
    Bonnick SL.
    J Clin Densitom; 2011 Sep 01; 14(4):377-83. PubMed ID: 22051091
    [No Abstract] [Full Text] [Related]

  • 28. Renal function and bisphosphonate safety.
    Ott SM, Drueke T, Elder G, Fukagawa M, Jorgetti V, Langman CB, Moe S, McCann L, Wang AY, Weisinger J, Wheeler D.
    J Bone Miner Res; 2008 Mar 01; 23(3):453-4; author reply 455. PubMed ID: 17967135
    [No Abstract] [Full Text] [Related]

  • 29. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S, Klemes AB, Zhou X, Lindsay R.
    J Am Geriatr Soc; 2010 Apr 01; 58(4):658-63. PubMed ID: 20345865
    [Abstract] [Full Text] [Related]

  • 30. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J.
    Bone; 2007 Jul 01; 41(1):122-8. PubMed ID: 17468062
    [Abstract] [Full Text] [Related]

  • 31. Preventing osteoporotic fractures with alendronate.
    Maughan KL.
    J Fam Pract; 1997 Apr 01; 44(4):336. PubMed ID: 9148031
    [No Abstract] [Full Text] [Related]

  • 32. [Correlation between studies and general practice].
    MMW Fortschr Med; 2006 Nov 16; 148(46):49. PubMed ID: 17615791
    [No Abstract] [Full Text] [Related]

  • 33. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec 16; 14(80):207-11. PubMed ID: 16397977
    [Abstract] [Full Text] [Related]

  • 34. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
    Rizzoli R, Greenspan SL, Bone G, Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA, Uebelhart B, Santora AC, Kaur A, Peverly CA, Orloff JJ, Alendronate Once-Weekly Study Group.
    J Bone Miner Res; 2002 Nov 16; 17(11):1988-96. PubMed ID: 12412806
    [Abstract] [Full Text] [Related]

  • 35. [Efficacy and tolerability of risedronate for the treatment of osteoporosis].
    Kishimoto H.
    Clin Calcium; 2008 Oct 16; 18(10):1417-26. PubMed ID: 18830038
    [Abstract] [Full Text] [Related]

  • 36. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials.
    Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE.
    J Bone Miner Res; 2005 Dec 16; 20(12):2105-15. PubMed ID: 16294264
    [Abstract] [Full Text] [Related]

  • 37. [To treat effectively without delay. The data on fractures decisive].
    MMW Fortschr Med; 2003 May 22; 145(21):56-7. PubMed ID: 12845873
    [No Abstract] [Full Text] [Related]

  • 38. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug 22; 18(102):175. PubMed ID: 19746563
    [Abstract] [Full Text] [Related]

  • 39. [Risedronate (Actonel)--from randomized clinical trials to real life].
    Anić B.
    Reumatizam; 2007 Aug 22; 54(2):85-6. PubMed ID: 18351152
    [No Abstract] [Full Text] [Related]

  • 40. Cyclical alendronate treatment in postmenopausal women with osteoporosis.
    Köşüş A, Capar M, Köşüş N.
    Int J Gynaecol Obstet; 2005 Nov 22; 91(2):182-4. PubMed ID: 16098978
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.